Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
for source : Www.fda.gov save search
FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants
Published: 2023-10-26 (Crawled : 15:30) - fda.gov
ABT | News | $107.07 -0.2% 0.18% 3.8M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
fda
FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes
Published: 2023-10-24 (Crawled : 20:00) - fda.gov
ABT | News | $107.07 -0.2% 0.18% 3.8M
|
Health Technology
|
| O: -0.89%
H: 0.09%
C: -1.04%
fda rare blood therapy
FDA Approves First Oral Treatment for Postpartum Depression
Published: 2023-08-04 (Crawled : 23:00) - fda.gov
SAGE | $12.89 -3.3% -3.25% 800K
|
Health Technology
| Email alert
Add to watchlist
fda depression treatment
FDA Approves First Gene Therapy for Adults with Severe Hemophilia A
Published: 2023-06-29 (Crawled : 22:00) - fda.gov
BMRN | $89.49 0.97% 0.99% 1.3M
|
Health Technology
|
| O: 1.2%
H: 1.97%
C: -3.69%
fda therapy
FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy
Published: 2023-06-22 (Crawled : 18:00) - fda.gov
SRPT | $116.96 1.16% 1.31% 890K
|
Health Technology
|
| O: -3.2%
H: 0.03%
C: -4.89%
fda treatment duchenne therapy
FDA Approves First Systemic Treatment for Alopecia Areata
Published: 2022-06-13 (Crawled : 20:00) - fda.gov
LLY | News | $731.33 0.69% 0.36% 1.7M
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
treatment fda
FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them
Published: 2021-12-23 (Crawled : 14:30) - fda.gov
XXII 4 | $1.65 1.85% 2.11% 220K
|
Health Technology
|
| O: 11.82%
H: 43.09%
C: 23.98%
fda
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
Published: 2021-10-27 (Crawled : 20:00) - fda.gov
TMO | News | $548.38 0.66% 0.86% 1.2M
|
Health Technology
|
| O: 0.44%
H: 2.01%
C: 0.82%
TAK | News | $13.36 0.91% 0.0% 1.5M
|
Health Technology
|
| O: 2.03%
H: 3.33%
C: 0.07%
RGNX | $15.64 -0.32% -0.06% 440K
|
Health Technology
|
| O: 0.91%
H: 2.93%
C: 2.79%
BIIB | $194.11 -0.14% -0.15% 930K
|
Health Technology
|
| O: 0.19%
H: 2.32%
C: 1.7%
disease fda gene therapies therapy gene therapy rare
FDA Grants First of its Kind Indication for Chronic Sleep Disorder Treatment
Published: 2021-08-12 (Crawled : 21:00) - fda.gov
JAZZ | $108.83 -1.01% -1.04% 510K
|
Health Technology
|
| O: -0.14%
H: 1.0%
C: -2.26%
treatment fda granted grant
Global Regulators Envision Paradigm Shift Toward Inclusion of Pregnant and Breastfeeding Women in Clinical Research for Medicines and Vaccines
Published: 2021-07-19 (Crawled : 00:00) - fda.gov
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.01%
H: 2.34%
C: 0.93%
vaccine
FDA approves selpercatinib for lung and thyroid cancers with RET gene mutations or fusions
Published: 2021-06-11 (Crawled : 18:17) - fda.gov
LLY | News | $731.33 0.69% 0.36% 1.7M
|
Health Technology
| Email alert
Add to watchlist
fda fda approval cancer
FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer
Published: 2021-06-11 (Crawled : 18:03) - fda.gov
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.5%
H: 0.33%
C: -3.67%
approval fda granted cancer prostate cancer grant
FDA approves nivolumab plus ipilimumab for first-line mNSCLC (PD-L1 tumor expression ≥1%)
Published: 2021-06-11 (Crawled : 18:03) - fda.gov
A | $133.91 0.89% 0.8% 600K
|
Health Technology
|
| O: 0.21%
H: 0.17%
C: 0.12%
approval fda fda approval nivolumab
FDA approves ramucirumab plus erlotinib for first-line metastatic NSCLC
Published: 2021-06-11 (Crawled : 17:07) - fda.gov
LLY | News | $731.33 0.69% 0.36% 1.7M
|
Health Technology
|
| O: -2.79%
H: 1.13%
C: -1.29%
fda approval fda approval
FDA grants regular approval to venetoclax in combination for untreated acute myeloid leukemia
Published: 2021-06-11 (Crawled : 14:04) - fda.gov
ABBV | News | $167.89 0.89% 0.51% 3.6M
|
Health Technology
|
| O: 0.0%
H: 0.1%
C: -0.71%
fda granted approval leukemia myeloid leukemia grant acute myeloid leukemia
FDA approves liquid biopsy NGS companion diagnostic test for multiple cancers and biomarkers
Published: 2021-06-11 (Crawled : 13:55) - fda.gov
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.5%
H: 0.33%
C: -3.67%
cancer test fda fda approval diagnostic biomarkers
FDA approves selinexor for refractory or relapsed multiple myeloma
Published: 2021-06-11 (Crawled : 13:47) - fda.gov
KPTI | $1.13 -3.42% -4.46% 690K
|
Health Technology
|
| O: 1.61%
H: 0.09%
C: -3.73%
fda approval fda approval
FDA approves pralsetinib for RET-altered thyroid cancers
Published: 2021-06-11 (Crawled : 13:47) - fda.gov
BPMC | $90.61 4.33% 4.23% 790K
|
Health Technology
|
| O: 1.41%
H: 2.24%
C: 1.88%
cancer fda approval fda approval
FDA grants accelerated approval to naxitamab for high-risk neuroblastoma in bone or bone marrow
Published: 2021-06-11 (Crawled : 13:47) - fda.gov
YMAB | $15.16 0.2% 0.46% 470K
|
Health Technology
|
| O: 0.05%
H: 1.54%
C: -3.36%
risk fda granted approval grant
FDA approves cemiplimab-rwlc for non-small cell lung cancer with high PD-L1 expression
Published: 2021-06-11 (Crawled : 13:10) - fda.gov
REGN | News | $900.16 0.37% 0.32% 240K
|
Health Technology
|
| O: -0.52%
H: 0.18%
C: -0.7%
cancer fda fda approval
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
PROK | $2.72 33.33% 24.58% 2.6M
|
Your saved searches
Save your searches and get alerts when important news are released.